公开(公告)号：US20230194447A1

公开(公告)日：2023-06-22

申请号：US18170114

申请日：2023-02-16

Applicant: UNIVERSITY OF MARYLAND, BALTIMORE ,  ACCESS TO ADVANCED HEALTH INSTITUTE

Inventor： Yihua (Bruce) YU ,  Marc TARABAN ,  Christopher FOX

IPC: G01N24/08 ,  G01N33/15

CPC classification number: G01N24/082 ,  G01N33/15

Abstract: A method of using the transverse relaxation rate (R2) of solvent NMR signal to noninvasively assess alum-containing products such as vaccines. This technique can be used for quality control in vaccine manufacturing (e.g., fill-finish step) to determine the evenness of alum filling level as well as extent of alum particle sedimentation in filled and sealed products.

公开(公告)号：US20230116042A1

公开(公告)日：2023-04-13

申请号：US17960110

申请日：2022-10-04

Applicant: ACCESS TO ADVANCED HEALTH INSTITUTE

Inventor： Christopher FOX ,  Steven G. REED ,  Susan BALDWIN ,  Thomas VEDVICK

IPC: A61K9/113 ,  A61K39/00 ,  A61K9/107 ,  A61K39/39 ,  A61K39/12 ,  A61K47/06 ,  A61K47/24 ,  A61K39/015 ,  A61K47/26

Abstract: Formulations and methods, including vaccines and pharmaceutical compositions for inducing or enhancing an immune response are disclosed. The formulations generally comprise a TLR4 agonist and a metabolizable oil at a concentration of about 0.01%-1% v/v, wherein the hydrophobic:lipophilic balance (HLB) of the emusion is greater than about 9.